Actavis Laboratories UT, Inc.

Form 483 issued August 20, 2021 · Salt Lake City, Utah

Inspection
Aug 16 – Aug 20, 2021
Observations
1
Pages
1
FEI number
1000117147

In short: On August 20, 2021, FDA issued a Form 483 with 1 observation to Actavis Laboratories UT, Inc. in Salt Lake City, Utah (FEI 1000117147) after an inspection that ran Aug 16 – Aug 20, 2021. The investigators were Alan P. Kurtzberg and Dustin M. James. Most observations concern packaging & labeling; the most-cited regulation is 21 CFR 211.122 (materials examination and usage criteria).

At a glance

1 of 1 observations on this 483 concern packaging & labeling.

Packaging & labeling1

Most cited: 21 CFR 211.122(d) (1×)

What FDA observed

Preview: the opening words of each observation
  1. 01

    Labels and other labeling materials are not stored separately with suitable identification for each different drug…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Actavis Laboratories UT, Inc.?

FDA listed 1 observation on this Form 483, mostly about packaging & labeling. The most-cited regulation is 21 CFR 211.122 (materials examination and usage criteria). The opening words of each observation are shown on this page.

Who inspected Actavis Laboratories UT, Inc.?

Alan P. Kurtzberg and Dustin M. James are named on this Form 483, for the inspection of Aug 16 – Aug 20, 2021. Each investigator has a profile showing what they cite most.

When was Actavis Laboratories UT, Inc. inspected by FDA?

The inspection ran Aug 16 – Aug 20, 2021, and the Form 483 is dated August 20, 2021.

How do I get the full Form 483 for Actavis Laboratories UT, Inc.?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free